Ra Pharmaceuticals, Inc. Insider Trading for June 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ra Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Ra Pharmaceuticals, Inc. for June 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 25 2019 | RARX | Ra Pharmaceuticals ... | Ricardo Alonso | See Remarks | Sell | S | 23.72 | 2,857 | 67,782 | 11,428 | 14.3 K to 11.4 K (-20.00 %) |
| Jun 19 2019 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Option Exercise | M | 2.87 | 10,000 | 28,700 | 106,142 | |
| Jun 19 2019 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Sell | S | 23.09 | 414 | 9,560 | 6,234 | 6.6 K to 6.2 K (-6.23 %) |
| Jun 19 2019 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Sell | S | 22.21 | 9,586 | 212,908 | 6,648 | 16.2 K to 6.6 K (-59.05 %) |
| Jun 19 2019 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Buy | M | 2.87 | 10,000 | 28,700 | 16,234 | 6.2 K to 16.2 K (+160.41 %) |
| Jun 19 2019 | RARX | Ra Pharmaceuticals ... | Farzaneh-Far Ramin | Chief Medical Offic ... | Option Exercise | M | 5.60 | 9,206 | 51,554 | 156,508 | |
| Jun 19 2019 | RARX | Ra Pharmaceuticals ... | Farzaneh-Far Ramin | Chief Medical Offic ... | Option Exercise | M | 5.60 | 1,389 | 7,778 | 23,611 | |
| Jun 19 2019 | RARX | Ra Pharmaceuticals ... | Farzaneh-Far Ramin | Chief Medical Offic ... | Sell | S | 22.04 | 7,184 | 158,363 | 7,132 | 14.3 K to 7.1 K (-50.18 %) |
| Jun 19 2019 | RARX | Ra Pharmaceuticals ... | Farzaneh-Far Ramin | Chief Medical Offic ... | Sell | S | 21.41 | 3,411 | 73,021 | 14,316 | 17.7 K to 14.3 K (-19.24 %) |
| Jun 19 2019 | RARX | Ra Pharmaceuticals ... | Farzaneh-Far Ramin | Chief Medical Offic ... | Buy | M | 5.60 | 9,206 | 51,554 | 17,727 | 8.5 K to 17.7 K (+108.04 %) |
| Jun 19 2019 | RARX | Ra Pharmaceuticals ... | Farzaneh-Far Ramin | Chief Medical Offic ... | Buy | M | 5.60 | 1,389 | 7,778 | 8,521 | 7.1 K to 8.5 K (+19.48 %) |
| Jun 13 2019 | RARX | Ra Pharmaceuticals ... | Shah Rajeev M. | Director | Option Exercise | A | 19.88 | 15,000 | 298,200 | 15,000 | |
| Jun 13 2019 | RARX | Ra Pharmaceuticals ... | Cumbo Alexander | Director | Option Exercise | A | 19.88 | 15,000 | 298,200 | 15,000 | |
| Jun 13 2019 | RARX | Ra Pharmaceuticals ... | PEARSON TIMOTHY R | Director | Option Exercise | A | 19.88 | 15,000 | 298,200 | 15,000 | |
| Jun 13 2019 | RARX | Ra Pharmaceuticals ... | Brennan Aoife | Director | Option Exercise | A | 19.88 | 15,000 | 298,200 | 15,000 | |
| Jun 13 2019 | RARX | Ra Pharmaceuticals ... | Heft Robert | Director | Option Exercise | A | 19.88 | 15,000 | 298,200 | 15,000 | |
| Jun 13 2019 | RARX | Ra Pharmaceuticals ... | RA CAPITAL MANAGEMENT, LLC | Director | Option Exercise | A | 19.88 | 15,000 | 298,200 | 15,000 | |
| Jun 13 2019 | RARX | Ra Pharmaceuticals ... | Mathers Edward T | Director | Option Exercise | A | 19.88 | 15,000 | 298,200 | 15,000 |